Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

(NASDAQ:VKTX) stands against the other multibagger stocks. The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs. Much of this optimism in the broader ...

Viking Therapeutics, Inc. (VKTX) stock price is 32.65 and Viking Therapeutics, Inc. (VKTX) 10-day simple moving average is 38.83. Viking Therapeutics, Inc. (VKTX) stock price is 32.65 and Viking ...

In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against the other multibagger stocks. The US equities continued their upward movement in 2024 and ...

The SBI International Access - US Equity FoF Regular Growth has an AUM of 960.77 crores & has delivered CAGR of 0.00% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio ...